NEWS INSIGHTS
Psychedelics activists protest outside DEA headquarters for access to psilocybin therapy
Oct
On Monday, September 20th, a group of psychedelics activists gathered outside of the Drug Enforcement Administration (DEA) headquarters to demand access to psilocybin therapy, the active ingredient in magic mushrooms. Activists organized the protest in response to the DEA’s recent decision to maintain psilocybin as a Schedule I substance, alongside drugs such as heroin and LSD, with no medical uses and high potential for abuse.
“We are here today to demand that the DEA reconsider their stance on psilocybin,” stated John Smith, president of ABC. “Scientific research has shown that psilocybin can have significant therapeutic benefits, particularly for those suffering from mental health issues like depression and anxiety. It is time for our government to acknowledge these benefits and take action to make this medicine more accessible.
” The protest included a peaceful march around the DEA building and speeches from various activists and experts in the field. They were joined by several individuals who have personally benefited from using psilocybin as a treatment for their mental health conditions. “The use of psychedelics is not about getting high or partying,” explained Sarah Jones
